B-
BiotechTV - News
Jefferies London 2026: CRISPR Therapeutics CEO Sam Kulkarni walks us through the company's increasingly advancing pipeline, which includes an siRNA
0:00-16:44
He discusses ANGPTL3 in cardiology and allo CAR-T, both of which recently had data at medical meedings. Plus the idea behind branching out to siRNA, which targets FXI for thrombotic conditions.
Publisher
BiotechTV - News
Link
podcasters.spotify.com/pod/show/biotechtv4/episodes/Jefferies-London-2026-CRISPR-Therapeutics-CEO-Sam-Kulkarni-walks-us-through-the-companys-increasingly-advancing-pipeline--which-includes-an-siRNA-e3shur5
Published
November 17, 2026
Duration
17 min
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
BiotechTV
B-
BiotechTV - News
@biotechtvnews
#jefferieslondon #crisprtherapeuticsceo #companysincreasinglyadvancing #lifesciences
